Targeting mitochondrial oxidative metabolism as an approach to treat heart failure.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2013-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbamcr.2012.08.014PMID 22960640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification and Functional Expression of the Mitochondrial Pyruvate Carrier

  2012cited by this paper
• Cardiac-Specific Deletion of Acetyl CoA Carboxylase 2 Prevents Metabolic Remodeling During Pressure-Overload Hypertrophy

  2012cited by this paper
• A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans

  2012cited by this paper
• Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.

  2011cited by this paper
• Ranolazine for the Treatment of Heart Failure With Preserved Ejection Fraction: Background, Aims, and Design of the RALI‐DHF Study

  2011cited by this paper
• Myocardial fatty acid metabolism in health and disease.

  2010cited by this paper
• Treatment and Risk in Heart Failure: Gaps in Evidence or Quality?

  2010cited by this paper
• Analysis of Metabolic Remodeling in Compensated Left Ventricular Hypertrophy and Heart Failure

  2010cited by this paper
• Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial

  2010cited by this paper
• Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure.

  2010cited by this paper
• Ranolazine Improves Cardiac Diastolic Dysfunction Through Modulation of Myofilament Calcium Sensitivity

  2010cited by this paper
• Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality.

  2010cited by this paper
• Metabolic Modulator Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy

  2010cited by this paper
• Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.

  2010cited by this paper
• Insulin-Stimulated Cardiac Glucose Oxidation Is Increased in High-Fat Diet–Induced Obese Mice Lacking Malonyl CoA Decarboxylase

  2009cited by this paper
• Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.

  2009cited by this paper
• Substrate–Enzyme Competition Attenuates Upregulated Anaplerotic Flux Through Malic Enzyme in Hypertrophied Rat Heart and Restores Triacylglyceride Content: Attenuating Upregulated Anaplerosis in Hypertrophy

  2009cited by this paper
• Cellular fatty acid uptake: a pathway under construction.

  2009cited by this paper
• Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy

  2008cited by this paper
• Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure.

  2008cited by this paper
• Essential Role for Uncoupling Protein-3 in Mitochondrial Adaptation to Fasting but Not in Fatty Acid Oxidation or Fatty Acid Anion Export*

  2008cited by this paper
• The absence of endogenous lipid oxidation in early stage heart failure exposes limits in lipid storage and turnover.

  2008cited by this paper
• The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations.

  2008cited by this paper
• Medium-chain Fatty Acids as Metabolic Therapy in Cardiac Disease

  2008cited by this paper
• Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.

  2008cited by this paper
• Protein-mediated fatty acid uptake: regulation by contraction, AMP-activated protein kinase, and endocrine signals.

  2007cited by this paper
• Surgical animal models of heart failure related to coronary heart disease.

  2007cited by this paper
• Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart.

  2007cited by this paper
• Nuclear receptors PPARβ/δ and PPARα direct distinct metabolic regulatory programs in the mouse heart

  2007cited by this paper
• CARNITINE PALMITOYL TRANSFERASE‐I INHIBITION IS NOT ASSOCIATED WITH CARDIAC HYPERTROPHY IN RATS FED A HIGH‐FAT DIET

  2007cited by this paper
• Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy.

  2007cited by this paper
• Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

  2007cited by this paper
• PPARdelta, but not PPARalpha, activates PGC-1alpha gene transcription in muscle.

  2007cited by this paper
• Fluid retention with thiazolidinediones: does the mechanism influence the outcome?

  2007cited by this paper
• The failing heart--an engine out of fuel.

  2007cited by this paper
• A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose oxidation) study.

  2007cited by this paper
• PPARd, but not PPARa, activates PGC-1a gene transcription in muscle

  2007cited by this paper
• Cardiac Energy Metabolism in Obesity

  2007cited by this paper
• Discovery of potent and orally available malonyl-CoA decarboxylase inhibitors as cardioprotective agents.

  2006cited by this paper
• Heteroaryl substituted bis-trifluoromethyl carbinols as malonyl-CoA decarboxylase inhibitors.

  2006cited by this paper
• Specific and sustained down-regulation of genes involved in fatty acid metabolism is not a hallmark of progression to cardiac failure in mice.

  2006cited by this paper
• Free Fatty Acid Depletion Acutely Decreases Cardiac Work and Efficiency in Cardiomyopathic Heart Failure

  2006cited by this paper
• A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.

  2006cited by this paper
• Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.

  2006cited by this paper
• Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle.

  2005cited by this paper
• Cardiac fatty acid metabolism is preserved in the compensated hypertrophic rat heart

  2005cited by this paper
• Metabolic Modulation With Perhexiline in Chronic Heart Failure: A Randomized, Controlled Trial of Short-Term Use of a Novel Treatment

  2005cited by this paper
• Trimetazidine Normalizes Postischemic Function of Hypertrophied Rat Hearts

  2005cited by this paper
• Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

  2005cited by this paper
• Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia.

  2005cited by this paper
• Myocardial substrate metabolism in the normal and failing heart.

  2005cited by this paper
• Heart failure

  2005cited by this paper
• Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

  2005cited by this paper
• Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury.

  2005cited by this paper
• Selective versus nonselective β‐adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization

  2005cited by this paper
• Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy.

  2005cited by this paper
• Animal models of heart failure: what is new?

  2005cited by this paper
• Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure.

  2004cited by this paper
• Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy

  2004cited by this paper
• Malonyl Coenzyme A Decarboxylase Inhibition Protects the Ischemic Heart by Inhibiting Fatty Acid Oxidation and Stimulating Glucose Oxidation

  2004cited by this paper
• Uncoupling proteins in human heart.

  2004cited by this paper
• Apolipoprotein B Production Reduces Lipotoxic Cardiomyopathy

  2004cited by this paper
• Effects of Medium-chain Triglyceride (MCT) Application to SHR on Cardiac Function, Hypertrophy and Expression of Endothelin-1 mRNA and other Genes

  2004cited by this paper
• Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?

  2004cited by this paper
• The Antianginal Agent Trimetazidine Does Not Exert Its Functional Benefit via Inhibition of Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase

  2003cited by this paper
• Lipotoxicity: when tissues overeat

  2003cited by this paper
• Upregulation of GLUT1 expression is necessary for hypertrophy and survival of neonatal rat cardiomyocytes.

  2003cited by this paper
• Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy.

  2003cited by this paper
• AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2.

  2003cited by this paper
• Beneficial Effects of Trimetazidine in Ex Vivo Working Ischemic Hearts Are Due to a Stimulation of Glucose Oxidation Secondary to Inhibition of Long-Chain 3-Ketoacyl Coenzyme A Thiolase

  2003cited by this paper
• Activation of Peroxisome Proliferator–Activated Receptor-&agr; Protects the Heart From Ischemia/Reperfusion Injury

  2003cited by this paper
• A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content

  2003cited by this paper
• Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs.

  2003cited by this paper
• Peroxisome Proliferator-Activated Receptor (PPAR) &agr; and PPAR&bgr;/&dgr;, but not PPAR&ggr;, Modulate the Expression of Genes Involved in Cardiac Lipid Metabolism

  2003cited by this paper
• Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation.

  2003cited by this paper
• Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

  2002cited by this paper
• Regulation of Pyruvate Dehydrogenase (PDH) Activity in Human Skeletal Muscle During Exercise

  2002cited by this paper
• Impaired Myocardial Fatty Acid Oxidation and Reduced Protein Expression of Retinoid X Receptor-&agr; in Pacing-Induced Heart Failure

  2002cited by this paper
• High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation.

  2002cited by this paper
• Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure.

  2002cited by this paper
• Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy.

  2002cited by this paper
• Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.

  2002cited by this paper
• Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure.

  2002cited by this paper
• The endosomal compartment is an insulin-sensitive recruitment site for GLUT4 and GLUT1 glucose transporters in cardiac myocytes.

  2001cited by this paper
• Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure

  2001cited by this paper
• Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyperthyroid rat heart.

  2001cited by this paper
• Uncoupling protein 3 transcription is regulated by peroxisome proliferator‐activated receptor α in the adult rodent heart

  2001cited by this paper
• Defective Fatty Acid Uptake in the Spontaneously Hypertensive Rat Is a Primary Determinant of Altered Glucose Metabolism, Hyperinsulinemia, and Myocardial Hypertrophy*

  2001cited by this paper
• Acute hibernation decreases myocardial pyruvate carboxylation and citrate release.

  2001cited by this paper
• Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites.

  2001cited by this paper
• Site Specificity of Four Pyruvate Dehydrogenase Kinase Isoenzymes toward the Three Phosphorylation Sites of Human Pyruvate Dehydrogenase*

  2001cited by this paper
• The Endosomal Compartment Is an Insulin-Sensitive Recruitment Site for GLUT4 and GLUT1 Glucose Transporters in Cardiac Myocytes.

  2001cited by this paper
• Troglitazone improves recovery of left ventricular function after regional ischemia in pigs.

  2000cited by this paper
• Anilides of (R)-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase.

  2000cited by this paper
• Less Extrahepatic Induction of Fatty Acid β-Oxidation Enzymes by PPARα

  2000cited by this paper
• Partitioning of pyruvate between oxidation and anaplerosis in swine hearts.

  2000cited by this paper
• Cardiac fatty acid uptake and transport in health and disease.

  2000cited by this paper
• Less extrahepatic induction of fatty acid beta-oxidation enzymes by PPAR alpha.

  2000cited by this paper
• Sarcoplasmic reticulum function and carnitine palmitoyltransferase‐1 inhibition during progression of heart failure

  2000cited by this paper
• The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.

  2000cited by this paper

• The triglyceride-glucose index is inversely associated with atrial fibrillation in patients with hypertrophic cardiomyopathy: evidence from a cross-sectional study.

  2026cites this paper
• ERK1/2 Inhibition Alleviates Diabetic Cardiomyopathy by Suppressing Fatty Acid Metabolism.

  2025cites this paper
• Dodecanedioic Acid: Alternative Carbon Substrate or Toxic Metabolite?

  2025cites this paper
• Development of a Quantitative Systems Pharmacology Model to Interrogate Mitochondrial Metabolism in Heart Failure

  2025cites this paper
• CROTONALDEHDE ORAL EXPOSURE DISRUPT CARDIAC ENERGY METABOLISM AND INDUCES OXIDATIVE STRESS VIA DOWN-REGULATION OF NRF-2 AND UP-REGULATION OF PPARα.

  2025cites this paper
• CPT1A exacerbates trastuzumab-induced cardiotoxicity via promotion of mitochondrial dysfunction.

  2025cites this paper
• Nicotinamide Adenine Dinucleotide Supplementation to Alleviate Heart Failure: A Mitochondrial Dysfunction Perspective

  2025cites this paper
• Comparative cardiomyocyte differentiation potential of rat adipose-derived mesenchymal stem cells from two anatomical sites: metabolomic profiling and pathway analysis

  2025cites this paper
• Prophylactic administration of kanli granule maintains fatty acid oxidation in the myocardium to prevent heart failure via activating AMPK/PPARα/CPT1A pathway: A network pharmacology-based study.

  2025cites this paper
• Mitochondrial membrane chromatography: Discovery of mitochondrial targeting modulators

  2025cites this paper
• Ketone therapy improves cardiac function and structure in rodents with heart failure: A systematic review and meta-analysis.

  2025cites this paper
• The ketogenic diet does not improve cardiac function and blunts glucose oxidation in ischemic heart failure.

  2024cites this paper
• Energy metabolism and redox balance: How phytochemicals influence heart failure treatment.

  2024cites this paper
• Mitochondrial Transfer: Therapeutic Implications for Energy Metabolism in Heart Failure.

  2024cites this paper
• Mitochondrial Transplantation in Brain Disorders: Achievements, Methods, and Challenges.

  2024cites this paper
• Recent Advances Associated with Cardiometabolic Remodeling in Diabetes-induced Heart Failure.

  2024cites this paper
• Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin

  2024cites this paper
• Multitargeting in cardioprotection: An example of biaromatic compounds

  2023cites this paper
• Acquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension

  2023cites this paper
• High-Density Lipoprotein Lipidomics in Chronic Kidney Disease.

  2023cites this paper
• Mitochondrial transplantation: the advance to therapeutic application and molecular modulation

  2023cites this paper
• From Beats to Metabolism: The Heart at the Core of Interorgan Crosstalk.

  2023cites this paper
• Real-time resolution studies of the regulation of pyruvate-dependent lactate metabolism by hexokinases in single cells

  2023cites this paper
• Advances in Metabolic Remodeling and Intervention Strategies in Heart Failure

  2023cites this paper
• Increased acylcarnitines in infant heart failure indicate fatty acid oxidation inhibition: towards therapeutic options?

  2023cites this paper
• Comparative Metabolomics in Single Ventricle Patients after Fontan Palliation: A Strong Case for a Targeted Metabolic Therapy

  2023cites this paper
• KDM8 epigenetically controls cardiac metabolism to prevent initiation of dilated cardiomyopathy

  2023cites this paper
• Influence of cardiac function on intermittent hypoxia in rats fed with high-fat diet

  2022cites this paper
• Major ginsenosides from Panax ginseng promote aerobic cellular respiration and SIRT1-mediated mitochondrial biosynthesis in cardiomyocytes and neurons

  2022cites this paper
• Heart Failure and Drug Therapies: A Metabolic Review

  2022cites this paper
• The impact of diet upon mitochondrial physiology (Review)

  2022cites this paper
• Post-translational Acetylation Control of Cardiac Energy Metabolism

  2021cites this paper
• Sodium–glucose co-transporter 2 inhibition with empagli�ozin improves cardiac function in rats after cardiac arrest

  2021cites this paper
• Sodium–Glucose Co-Transporter 2 Inhibition With Empagliflozin Improves Cardiac Function After Cardiac Arrest in Rats by Enhancing Mitochondrial Energy Metabolism

  2021cites this paper
• Cardiomyocyte‐specific miR‐100 overexpression preserves heart function under pressure overload in mice and diminishes fatty acid uptake as well as ROS production by direct suppression of Nox4 and CD36

  2021cites this paper
• Ketone Ester D‐β‐Hydroxybutyrate‐(R)‐1,3 Butanediol Prevents Decline in Cardiac Function in Type 2 Diabetic Mice

  2021cites this paper
• Thyroid hormones and the potential for regulating glucose metabolism in cardiomyocytes during insulin resistance and T2DM

  2021cites this paper
• Interplay Between Reactive Oxygen/Reactive Nitrogen Species and Metabolism in Vascular Biology and Disease

  2021cites this paper
• Short-term administration of C. aronia stimulates insulin signaling, suppresses fatty acids metabolism, and increases glucose uptake and utilization in the hearts of healthy rats

  2021cites this paper
• Ketone Therapy for Heart Failure: Current Evidence for Clinical Use.

  2021cites this paper
• Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy

  2021cites this paper
• Cellular and molecular pathobiology of heart failure with preserved ejection fraction

  2021cites this paper
• Trimetazidine in Heart Failure

  2021cites this paper
• A procedure to extract functional isolated mitochondria from small-sized human atrial samples. Application to obesity with a partial characterisation of the organelles.

  2020cites this paper
• Danqi Pill Protects Against Heart Failure Post-Acute Myocardial Infarction via HIF-1α/PGC-1α Mediated Glucose Metabolism Pathway

  2020cites this paper
• The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15

  2020cites this paper
• Synthesis and characterization of novel 99mTc-DGC nano-complexes for improvement of heart diagnostic.

  2020cites this paper
• Metabolomics coupled with integrated approaches reveal the therapeutic effects of higenamine combined with [6]-gingerol on doxorubicin-induced chronic heart failure in rats

  2020cites this paper
• Mitochondrial movement between mammalian cells: an emerging physiological phenomenon

  2020cites this paper
• Qiliqiangxin prevents right ventricular remodeling by inhibiting apoptosis and improving metabolism reprogramming with pulmonary arterial hypertension.

  2020cites this paper
• Metabonomics coupled with integrated approach reveals the therapeutic effect of higenamine combined with [6]-gingerol on doxorubicin - induced chronic heart failure in rats

  2020influential citation
• Evolution of Altered Tubular Metabolism and Mitochondrial Function in Sepsis Associated Acute Kidney Injury.

  2020cites this paper
• Snail augments fatty acid oxidation by suppression of mitochondrial ACC2 during cancer progression

  2020cites this paper
• FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes

  2020cites this paper
• Mitochondrial control of gene expression and extrinsic apoptosis

  2019cites this paper
• p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities

  2019cites this paper
• Forms of extracellular mitochondria and their impact in health.

  2019cites this paper
• Low-Intensity Running and High-Intensity Swimming Exercises Differentially Improve Energy Metabolism in Mice With Mild Spinal Muscular Atrophy

  2019cites this paper
• Metabolomic Perspectives in Antiblastic Cardiotoxicity and Cardioprotection

  2019cites this paper
• Tortuous Paths of Insulin Signaling and Mitochondria in Alzheimer's Disease.

  2019cites this paper
• Right ventricular pressure overload alters cardiac lipid composition.

  2019cites this paper
• Chronic Pressure Overload Results in Deficiency of Mitochondrial Membrane Transporter ABCB7 Which Contributes to Iron Overload, Mitochondrial Dysfunction, Metabolic Shift and Worsens Cardiac Function

  2019cites this paper
• Antioxidant and Cardioprotective Effects of EPA on Early Low-Severity Sepsis through UCP3 and SIRT3 Upholding of the Mitochondrial Redox Potential

  2019cites this paper
• Titin truncations lead to impaired cardiomyocyte autophagy and mitochondrial function in vivo.

  2019cites this paper
• Dichloroacetate Ameliorates Cardiac Dysfunction Caused by Ischemic Insults Through AMPK Signal Pathway—Not Only Shifts Metabolism

  2018cites this paper
• Galectin-3 down-regulates antioxidant peroxiredoxin-4 in human cardiac fibroblasts: a new pathway to induce cardiac damage.

  2018cites this paper
• Defects in the mitochondrial-tRNA modification enzymes MTO1 and GTPBP3 promote different metabolic reprogramming through a HIF-PPARγ-UCP2-AMPK axis

  2018cites this paper
• Metabolic remodeling of substrate utilization during heart failure progression

  2018cites this paper
• Mitochondrial function in the heart: the insight into mechanisms and therapeutic potentials

  2018cites this paper
• Cardiomyocytes cultured on mechanically compliant substrates, but not on conventional culture devices, exhibit prominent mitochondrial dysfunction due to reactive oxygen species and insulin resistance under high glucose

  2018cites this paper
• Lysosomes Mediate Benefits of Intermittent Fasting in Cardiometabolic Disease: The Janitor Is the Undercover Boss.

  2018cites this paper
• Pyruvate dehydrogenase activation precedes the down-regulation of fatty acid oxidation in monocrotaline-induced myocardial toxicity in mice

  2018cites this paper
• Energetic metabolism in cardiomyocytes: molecular basis of heart ischemia and arrhythmogenesis

  2017cites this paper
• African Ancestry Gradient Is Associated with Lower Systemic F2-Isoprostane Levels

  2017cites this paper
• Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease

  2017cites this paper
• Mitochondrial transplantation: From animal models to clinical use in humans.

  2017cites this paper
• MicroRNAs 33, 122, and 208: a potential novel targets in the treatment of obesity, diabetes, and heart-related diseases

  2017cites this paper
• Mitochondria as a target of cardioprotection in models of preconditioning

  2017cites this paper
• Design, synthesis and in vitro evaluation of some small molecules malonyl CoA decarboxylase inhibitors containing pyrazoline scaffold and study of their binding interactions with malonyl CoA decarboxylase via preliminary docking simulation

  2017cites this paper
• Metabolic Modulators in Heart Disease: Past, Present, and Future.

  2017cites this paper
• Metabolic interventions in heart failure

  2017cites this paper
• Cardiac metabolism — A promising therapeutic target for heart failure

  2017cites this paper
• Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death

  2017cites this paper
• Cyclosporine A attenuates cardiac dysfunction induced by sepsis via inhibiting calcineurin and activating AMPK signaling.

  2017cites this paper
• University of Groningen Selecting heart failure patients for metabolic interventions

  2017cites this paper
• New drug targets and therapeutic approaches in heart failure

  2017influential citation
• QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS OF NOVEL PYRAZOLINE DERIVATIVES USING K NEAREST NEIGHBOUR MOLECULAR FIELD ANALYSIS METHOD

  2017cites this paper
• Selecting heart failure patients for metabolic interventions

  2017cites this paper
• Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failure

  2017cites this paper
• Peroxisome proliferator-activated receptors as therapeutic targets for heart failure.

  2017cites this paper
• Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria.

  2017cites this paper
• Aspalathin, a dihydrochalcone C-glucoside, protects H9c2 cardiomyocytes against high glucose induced shifts in substrate preference and apoptosis.

  2016cites this paper
• Effects of voluntary physical activity and endurance training in cardiac mitochondrial function of high-fat diet-fed rats.

  2016cites this paper
• Compounds specific to Aspalathus linearis protects the diabetic heart against oxidative stress: a mechanistic study

  2016cites this paper
• Remodelling of the cardiac caveolar domain in heart failure and its putative influence on beta adrenergic signalling

  2016cites this paper
• Increased Pyruvate Dehydrogenase Kinase 4 Expression in Lung Pericytes Is Associated with Reduced Endothelial-Pericyte Interactions and Small Vessel Loss in Pulmonary Arterial Hypertension.

  2016cites this paper
• Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart.

  2016cites this paper
• Energy production in the reperfused ischemic heart

  2016cites this paper
• Pathophysiology of Heart Failure and an Overview of Therapies

  2016cites this paper
• Prognostic Implications of Long-Chain Acylcarnitines in Heart Failure and Reversibility With Mechanical Circulatory Support.

  2016cites this paper